Monthly Archives: May 2023
Mind the Ethical Gap in AI-Powered Drug Discovery
Dessislava Fessenko shows that while artificial intelligence might revolutionize drug development, its use comes with risks and potential ethical implications. Iterative ethics oversight from the get-go is needed to address the looming concerns.
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).




